6 Results for "

AZD3293

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "AZD3293" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-100740
CAS No.: 1383982-64-6
Purity:  99.87%
Synonyms: AZD3293; LY3314814
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

Lanabecestat (AZD3293; LY3314814) is a potent, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM. Lanabecestat is used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-100740B
CAS No.: 1522418-41-2
Synonyms: LY3314814 camsylate; AZD3293 camsylate
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

Lanabecestat (AZD3293; LY3314814) camsylate is a potent, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM. Lanabecestat camsylate is used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-100740R
CAS No.: 1383982-64-6
Synonyms: AZD3293 (Standard); LY3314814 (Standard)
Research Areas:  

Neurological Disease

Lanabecestat (Standard) is the analytical standard of Lanabecestat. This product is intended for research and analytical applications. Lanabecestat (AZD3293) is a potent, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM. Lanabecestat is used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-100740A
CAS No.: 1383986-31-9
Synonyms: AZD-3293 hydrochloride; LY3314814 hydrochloride
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

Lanabecestat (AZD3293; LY3314814) hydrochloride is a potent BACE1 inhibitor that has been investigated for its potential as a modifying treatment for Alzheimer's disease. Lanabecestat (hydrochloride) demonstrated significant dose- and time-dependent reductions in concentrations of amyloid beta peptides in plasma, cerebrospinal fluid, and brain. Lanabecestat (hydrochloride) was also shown to produce reductions in Aβ neuritic plaque burden without demonstrating clinical benefits or slowing the progression of Alzheimer's disease pathophysiology.
loading...
    loading...
Cat. No.: HY-100740C
CAS No.: 1384082-96-5
Purity:  96.01%
Synonyms: (1α,1'S,4β)-AZD3293; (1α,1'S,4β)-LY3314814
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

(1α,1'S,4β)-Lanabecestat ((1α,1'S,4β)-AZD3293) a less active enantiomer of Lanabecestat. Lanabecestat is a potent, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM .
loading...
    loading...
Cat. No.: HY-100740CR
CAS No.: 1384082-96-5
Synonyms: (1α,1'S,4β)-AZD3293 (Standard); (1α,1'S,4β)-LY3314814 (Standard)
Research Areas:  

Neurological Disease

(1α,1'S,4β)-Lanabecestat (Standard) is the analytical standard of (1α,1'S,4β)-Lanabecestat (HY-100740C). This product is intended for research and analytical applications. (1α,1'S,4β)-Lanabecestat ((1α,1'S,4β)-AZD3293) a less active enantiomer of Lanabecestat. Lanabecestat is a potent, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM .
loading...
    loading...